Back to Results
First PageMeta Content
Chemistry / Electrolyte disturbances / Hypocalcaemia / Nephrology / Denosumab / Renal failure / Vitamin D / Calcium in biology / Hypercalcaemia / Calcium / Medicine / Biology


Dear Healthcare Professional Letter of Rapid Safety Communication September 2012 RANMARK SUBCUTANEOUS INJECTION 120mg (denosumab） -Risk of severe hypocalcaemia, including fatal cases 11 September 2012 Dear Healthcare P
Add to Reading List

Document Date: 2012-09-12 05:48:19

Open Document

File Size: 137,35 KB

Share Result on Facebook

City

Tokyo / /

Company

Chiyoda / DAIICHI SANKYO COMPANY LIMITED / Medical Devices Agency Translated / DAIICHI SANKYO COMPANY LIMITED Pharmaceuticals / /

/

Event

Product Issues / /

MedicalTreatment

emergency treatment / dialysis / /

Organization

I.V. administration / /

Product

vitamin D / RANMARK SUBCUTANEOUS INJECTION / activation / /

Technology

dialysis / /

SocialTag